{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:17:58Z","timestamp":1792783078159,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Dalian Municipal Health Commission\u2019s Peak Climbing Plan Project","award":["2022ZZ202"],"award-info":[{"award-number":["2022ZZ202"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10787-025-01757-3","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T23:28:29Z","timestamp":1745450909000},"page":"3317-3328","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Voclosporin promotes neurological function recovery by inhibiting inflammation and maintaining blood\u2013brain barrier integrity following rtPA reperfusion after MCAO in mice"],"prefix":"10.1007","volume":"33","author":[{"given":"Yangmin","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4464-2163","authenticated-orcid":false,"given":"Shubei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"issue":"5","key":"1757_CR1","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s40262-023-01246-2","volume":"62","author":"E Abdel-Kahaar","year":"2023","unstructured":"Abdel-Kahaar E, Keller F (2023) Clinical pharmacokinetics and pharmacodynamics of voclosporin. Clin Pharmacokinet 62(5):693\u2013703. https:\/\/doi.org\/10.1007\/s40262-023-01246-2","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"1757_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1385\/NMM:7:3:229","volume":"7","author":"TV Arumugam","year":"2005","unstructured":"Arumugam TV, Granger DN, Mattson MP (2005) Stroke and T-cells. Neuromol Med 7(3):229\u2013242. https:\/\/doi.org\/10.1385\/NMM:7:3:229","journal-title":"Neuromol Med"},{"issue":"1","key":"1757_CR3","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s12035-013-8538-z","volume":"49","author":"M Chaturvedi","year":"2014","unstructured":"Chaturvedi M, Kaczmarek L (2014) Mmp-9 inhibition: a therapeutic strategy in ischemic stroke. Mol Neurobiol 49(1):563\u2013573. https:\/\/doi.org\/10.1007\/s12035-013-8538-z","journal-title":"Mol Neurobiol"},{"issue":"7","key":"1757_CR4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41419-019-1716-9","volume":"10","author":"AQ Chen","year":"2019","unstructured":"Chen AQ, Fang Z, Chen XL, Yang S, Zhou YF, Mao L, Hu B (2019) Microglia-derived TNF-alpha mediates endothelial necroptosis aggravating blood brain-barrier disruption after ischemic stroke. Cell Death Dis 10(7):487. https:\/\/doi.org\/10.1038\/s41419-019-1716-9","journal-title":"Cell Death Dis"},{"issue":"1","key":"1757_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1747-4949.2009.00248.x","volume":"4","author":"S Davis","year":"2009","unstructured":"Davis S, Donnan G (2009) The ECASS III results and the tPA paradox. Int J Stroke 4(1):17\u201318. https:\/\/doi.org\/10.1111\/j.1747-4949.2009.00248.x","journal-title":"Int J Stroke"},{"key":"1757_CR6","doi-asserted-by":"publisher","first-page":"106641","DOI":"10.1016\/j.phrs.2022.106641","volume":"187","author":"Q He","year":"2023","unstructured":"He Q, Ma Y, Fang C, Deng Z, Wang F, Qu Y, Guo ZN (2023) Remote ischemic conditioning attenuates blood-brain barrier disruption after recombinant tissue plasminogen activator treatment via reducing PDGF-CC. Pharmacol Res 187:106641. https:\/\/doi.org\/10.1016\/j.phrs.2022.106641","journal-title":"Pharmacol Res"},{"issue":"5","key":"1757_CR7","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s40265-021-01488-z","volume":"81","author":"YA Heo","year":"2021","unstructured":"Heo YA (2021) Voclosporin: first approval. Drugs 81(5):605\u2013610. https:\/\/doi.org\/10.1007\/s40265-021-01488-z","journal-title":"Drugs"},{"key":"1757_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071639","author":"IH Hernandez","year":"2021","unstructured":"Hernandez IH, Villa-Gonzalez M, Martin G, Soto M, Perez-Alvarez MJ (2021) Glial cells as therapeutic approaches in brain ischemia\u2013reperfusion injury. Cells. https:\/\/doi.org\/10.3390\/cells10071639","journal-title":"Cells"},{"issue":"7","key":"1757_CR9","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/rheumatology\/keq031","volume":"49","author":"T Horiuchi","year":"2010","unstructured":"Horiuchi T, Mitoma H, Harashima S, Tsukamoto H, Shimoda T (2010) Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents. Rheumatology (Oxford) 49(7):1215\u20131228. https:\/\/doi.org\/10.1093\/rheumatology\/keq031","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"1757_CR10","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.2174\/1570159X18666200529150907","volume":"18","author":"R Kang","year":"2020","unstructured":"Kang R, Gamdzyk M, Lenahan C, Tang J, Tan S, Zhang JH (2020) The dual role of microglia in blood\u2013brain barrier dysfunction after stroke. Curr Neuropharmacol 18(12):1237\u20131249. https:\/\/doi.org\/10.2174\/1570159X18666200529150907","journal-title":"Curr Neuropharmacol"},{"key":"1757_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2024.110192","volume":"262","author":"H Kawa","year":"2025","unstructured":"Kawa H, Ahmed Z, Majid A, Chen R (2025) Inhibition of matrix metalloproteinases to reduce blood brain barrier disruption and haemorrhagic transformation in ischaemic stroke: go broad or go narrow? Neuropharmacology 262:110192. https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110192","journal-title":"Neuropharmacology"},{"issue":"9558","key":"1757_CR12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(07)60154-8","volume":"369","author":"AM Khaja","year":"2007","unstructured":"Khaja AM, Grotta JC (2007) Established treatments for acute ischaemic stroke. Lancet 369(9558):319\u2013330. https:\/\/doi.org\/10.1016\/S0140-6736(07)60154-8","journal-title":"Lancet"},{"key":"1757_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2023.114655","volume":"373","author":"N Khassafi","year":"2024","unstructured":"Khassafi N, Azami Tameh A, Mirzaei H, Rafat A, Barati S, Khassafi N, Vahidinia Z (2024) Crosstalk between Nrf2 signaling pathway and inflammation in ischemic stroke: mechanisms of action and therapeutic implications. Exp Neurol 373:114655. https:\/\/doi.org\/10.1016\/j.expneurol.2023.114655","journal-title":"Exp Neurol"},{"issue":"5","key":"1757_CR14","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1182\/bloodadvances.2023011744","volume":"8","author":"F Lebrun","year":"2024","unstructured":"Lebrun F, Levard D, Lemarchand E, Yetim M, Furon J, Potzeha F, Vivien D (2024) Improving stroke outcomes in hyperglycemic mice by modulating tPA\/NMDAR signaling to reduce inflammation and hemorrhages. Blood Adv 8(5):1330\u20131344. https:\/\/doi.org\/10.1182\/bloodadvances.2023011744","journal-title":"Blood Adv"},{"issue":"5","key":"1757_CR15","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/jcbfm.2014.9","volume":"34","author":"S Lenglet","year":"2014","unstructured":"Lenglet S, Montecucco F, Denes A, Coutts G, Pinteaux E, Mach F, Copin JC (2014) Recombinant tissue plasminogen activator enhances microglial cell recruitment after stroke in mice. J Cereb Blood Flow Metab 34(5):802\u2013812. https:\/\/doi.org\/10.1038\/jcbfm.2014.9","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"1757_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1006\/exnr.2000.7459","volume":"165","author":"PA Li","year":"2000","unstructured":"Li PA, Kristian T, He QP, Siesjo BK (2000) Cyclosporin A enhances survival, ameliorates brain damage, and prevents secondary mitochondrial dysfunction after a 30-minute period of transient cerebral ischemia. Exp Neurol 165(1):153\u2013163. https:\/\/doi.org\/10.1006\/exnr.2000.7459","journal-title":"Exp Neurol"},{"key":"1757_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.brainresbull.2018.11.006","volume":"144","author":"Y Li","year":"2019","unstructured":"Li Y, Zhong W, Jiang Z, Tang X (2019) New progress in the approaches for blood-brain barrier protection in acute ischemic stroke. Brain Res Bull 144:46\u201357. https:\/\/doi.org\/10.1016\/j.brainresbull.2018.11.006","journal-title":"Brain Res Bull"},{"issue":"1","key":"1757_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12951-023-01828-z","volume":"21","author":"Y Li","year":"2023","unstructured":"Li Y, Liu B, Zhao T, Quan X, Han Y, Cheng Y, Zhao Y (2023) Comparative study of extracellular vesicles derived from mesenchymal stem cells and brain endothelial cells attenuating blood-brain barrier permeability via regulating Caveolin-1-dependent ZO-1 and Claudin-5 endocytosis in acute ischemic stroke. J Nanobiotechnol 21(1):70. https:\/\/doi.org\/10.1186\/s12951-023-01828-z","journal-title":"J Nanobiotechnol"},{"key":"1757_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s12975-024-01258-5","author":"J Li","year":"2024","unstructured":"Li J, Wang Z, Li J, Zhao H, Ma Q (2024) HMGB1: a new target for ischemic stroke and hemorrhagic transformation. Transl Stroke Res. https:\/\/doi.org\/10.1007\/s12975-024-01258-5","journal-title":"Transl Stroke Res"},{"issue":"3","key":"1757_CR20","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s10571-020-00985-1","volume":"42","author":"C Liu","year":"2022","unstructured":"Liu C, Xie J, Sun S, Li H, Li T, Jiang C, Wang W (2022a) Hemorrhagic transformation after tissue plasminogen activator treatment in acute ischemic stroke. Cell Mol Neurobiol 42(3):621\u2013646. https:\/\/doi.org\/10.1007\/s10571-020-00985-1","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"1757_CR21","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12951-022-01474-x","volume":"20","author":"D Liu","year":"2022","unstructured":"Liu D, Ji Q, Cheng Y, Liu M, Zhang B, Mei Q, Zhou S (2022b) Cyclosporine A loaded brain targeting nanoparticle to treat cerebral ischemia\/reperfusion injury in mice. J Nanobiotechnol 20(1):256. https:\/\/doi.org\/10.1186\/s12951-022-01474-x","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"1757_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41420-023-01440-y","volume":"9","author":"J Long","year":"2023","unstructured":"Long J, Sun Y, Liu S, Yang S, Chen C, Zhang Z, Chen N (2023) Targeting pyroptosis as a preventive and therapeutic approach for stroke. Cell Death Discov 9(1):155. https:\/\/doi.org\/10.1038\/s41420-023-01440-y","journal-title":"Cell Death Discov"},{"issue":"5","key":"1757_CR23","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1227\/NEU.0b013e31820c6cdc","volume":"68","author":"D Lulic","year":"2011","unstructured":"Lulic D, Burns J, Bae EC, van Loveren H, Borlongan CV (2011) A review of laboratory and clinical data supporting the safety and efficacy of cyclosporin A in traumatic brain injury. Neurosurgery 68(5):1172\u20131185. https:\/\/doi.org\/10.1227\/NEU.0b013e31820c6cdc. (discussion 1185-1176)","journal-title":"Neurosurgery"},{"issue":"11","key":"1757_CR24","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1001\/jama.2020.26867","volume":"325","author":"SJ Mendelson","year":"2021","unstructured":"Mendelson SJ, Prabhakaran S (2021) Diagnosis and management of transient ischemic attack and acute ischemic stroke: a review. JAMA 325(11):1088\u20131098. https:\/\/doi.org\/10.1001\/jama.2020.26867","journal-title":"JAMA"},{"issue":"2","key":"1757_CR25","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1161\/STROKEAHA.120.029232","volume":"52","author":"FA Montellano","year":"2021","unstructured":"Montellano FA, Ungethum K, Ramiro L, Nacu A, Hellwig S, Fluri F, Heuschmann PU (2021) Role of blood-based biomarkers in ischemic stroke prognosis: a systematic review. Stroke 52(2):543\u2013551. https:\/\/doi.org\/10.1161\/STROKEAHA.120.029232","journal-title":"Stroke"},{"key":"1757_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3389\/fimmu.2020.00195","volume":"11","author":"YJ Park","year":"2020","unstructured":"Park YJ, Yoo SA, Kim M, Kim WU (2020) The role of calcium-calcineurin-NFAT signaling pathway in health and autoimmune diseases. Front Immunol 11:195. https:\/\/doi.org\/10.3389\/fimmu.2020.00195","journal-title":"Front Immunol"},{"issue":"6","key":"1757_CR27","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/glia.24501","volume":"72","author":"AM Planas","year":"2024","unstructured":"Planas AM (2024) Role of microglia in stroke. Glia 72(6):1016\u20131053. https:\/\/doi.org\/10.1002\/glia.24501","journal-title":"Glia"},{"issue":"10289","key":"1757_CR28","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1016\/S0140-6736(21)00578-X","volume":"397","author":"BH Rovin","year":"2021","unstructured":"Rovin BH, Teng YKO, Ginzler EM, Arriens C, Caster DJ, Romero-Diaz J, Huizinga RB (2021) Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet 397(10289):2070\u20132080. https:\/\/doi.org\/10.1016\/S0140-6736(21)00578-X","journal-title":"Lancet"},{"issue":"Suppl 2","key":"1757_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1471-4159.2012.07941.x","volume":"123","author":"T Shichita","year":"2012","unstructured":"Shichita T, Ago T, Kamouchi M, Kitazono T, Yoshimura A, Ooboshi H (2012) Novel therapeutic strategies targeting innate immune responses and early inflammation after stroke. J Neurochem 123(Suppl 2):29\u201338. https:\/\/doi.org\/10.1111\/j.1471-4159.2012.07941.x","journal-title":"J Neurochem"},{"issue":"3","key":"1757_CR30","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1007\/s12035-022-02725-6","volume":"59","author":"A Soltani Khaboushan","year":"2022","unstructured":"Soltani Khaboushan A, Yazdanpanah N, Rezaei N (2022) Neuroinflammation and proinflammatory cytokines in epileptogenesis. Mol Neurobiol 59(3):1724\u20131743. https:\/\/doi.org\/10.1007\/s12035-022-02725-6","journal-title":"Mol Neurobiol"},{"key":"1757_CR31","doi-asserted-by":"publisher","first-page":"155071","DOI":"10.1016\/j.phymed.2023.155071","volume":"120","author":"X Sun","year":"2023","unstructured":"Sun X, Liu Z, Zhou L, Ma R, Zhang X, Wang T, Wang Y (2023) Escin avoids hemorrhagic transformation in ischemic stroke by protecting BBB through the AMPK\/Cav-1\/MMP-9 pathway. Phytomedicine 120:155071. https:\/\/doi.org\/10.1016\/j.phymed.2023.155071","journal-title":"Phytomedicine"},{"issue":"3","key":"1757_CR32","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s11739-023-03201-2","volume":"18","author":"A Tirandi","year":"2023","unstructured":"Tirandi A, Sgura C, Carbone F, Montecucco F, Liberale L (2023) Inflammatory biomarkers of ischemic stroke. Internal Emerg Med 18(3):723\u2013732. https:\/\/doi.org\/10.1007\/s11739-023-03201-2","journal-title":"Internal Emerg Med"},{"issue":"1","key":"1757_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5853\/jos.2019.02236","volume":"22","author":"C Tschoe","year":"2020","unstructured":"Tschoe C, Bushnell CD, Duncan PW, Alexander-Miller MA, Wolfe SQ (2020) Neuroinflammation after intracerebral hemorrhage and potential therapeutic targets. J Stroke 22(1):29\u201346. https:\/\/doi.org\/10.5853\/jos.2019.02236","journal-title":"J Stroke"},{"issue":"5","key":"1757_CR34","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1080\/17512433.2022.2092470","volume":"15","author":"T van Gelder","year":"2022","unstructured":"van Gelder T, Lerma E, Engelke K, Huizinga RB (2022) Voclosporin: a novel calcineurin inhibitor for the treatment of lupus nephritis. Expert Rev Clin Pharmacol 15(5):515\u2013529. https:\/\/doi.org\/10.1080\/17512433.2022.2092470","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"5","key":"1757_CR35","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s40264-024-01398-5","volume":"47","author":"P Verona","year":"2024","unstructured":"Verona P, Edwards J, Hubert K, Avorio F, Re VL, Di Stefano R, Provenzani A (2024) Tacrolimus-induced neurotoxicity after transplant: a literature review. Drug Saf 47(5):419\u2013438. https:\/\/doi.org\/10.1007\/s40264-024-01398-5","journal-title":"Drug Saf"},{"issue":"11","key":"1757_CR36","doi-asserted-by":"publisher","first-page":"CD004293","DOI":"10.1002\/14651858.CD004293.pub4","volume":"11","author":"TC von Groote","year":"2021","unstructured":"von Groote TC, Williams G, Au EH, Chen Y, Mathew AT, Hodson EM, Tunnicliffe DJ (2021) Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome. Cochrane Database Syst Rev 11(11):CD004293. https:\/\/doi.org\/10.1002\/14651858.CD004293.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"1757_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107744","volume":"96","author":"G Wang","year":"2021","unstructured":"Wang G, Zhang H, Sun J, Zhang Y, He F, Zou J (2021) Cyclosporin A impairs neurogenesis and cognitive abilities in brain development via the IFN-gamma-Shh-BDNF pathway. Int Immunopharmacol 96:107744. https:\/\/doi.org\/10.1016\/j.intimp.2021.107744","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"1757_CR38","doi-asserted-by":"publisher","first-page":"CD000213","DOI":"10.1002\/14651858.CD000213.pub3","volume":"2014","author":"JM Wardlaw","year":"2014","unstructured":"Wardlaw JM, Murray V, Berge E, del Zoppo GJ (2014) Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2014(7):CD000213. https:\/\/doi.org\/10.1002\/14651858.CD000213.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"1757_CR39","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/cns.13899","volume":"28","author":"F Yu","year":"2022","unstructured":"Yu F, Wang Y, Stetler AR, Leak RK, Hu X, Chen J (2022) Phagocytic microglia and macrophages in brain injury and repair. CNS Neurosci Ther 28(9):1279\u20131293. https:\/\/doi.org\/10.1111\/cns.13899","journal-title":"CNS Neurosci Ther"},{"key":"1757_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2022.147937","volume":"1788","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Gan L, Ren L, Lin Y, Ma C, Lin X (2022) Factors influencing the blood-brain barrier permeability. Brain Res 1788:147937. https:\/\/doi.org\/10.1016\/j.brainres.2022.147937","journal-title":"Brain Res"},{"issue":"12","key":"1757_CR41","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1111\/cns.13961","volume":"28","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, Hu Y, Han Z, Yan F, Zhang S, Yang Z, Luo Y (2022) Lomitapide ameliorates middle cerebral artery occlusion-induced cerebral ischemia\/reperfusion injury by promoting neuronal autophagy and inhibiting microglial migration. CNS Neurosci Ther 28(12):2183\u20132194. https:\/\/doi.org\/10.1111\/cns.13961","journal-title":"CNS Neurosci Ther"},{"issue":"4","key":"1757_CR42","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/01616412.2024.2328481","volume":"46","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Hu Y, Yan F, Wang R, Tao Z, Fan J, Luo Y (2024) Dihydroergotamine protects against ischemic stroke by modulating microglial\/macrophage polarization and inhibiting inflammation in mice. Neurol Res 46(4):367\u2013377. https:\/\/doi.org\/10.1080\/01616412.2024.2328481","journal-title":"Neurol Res"},{"issue":"8","key":"1757_CR43","doi-asserted-by":"publisher","first-page":"e70000","DOI":"10.1111\/cns.70000","volume":"30","author":"L Zhong","year":"2024","unstructured":"Zhong L, Fan J, Yan F, Yang Z, Hu Y, Li L, Liu P (2024) Long noncoding RNA H19 knockdown promotes angiogenesis via IMP2 after ischemic stroke. CNS Neurosci Ther 30(8):e70000. https:\/\/doi.org\/10.1111\/cns.70000","journal-title":"CNS Neurosci Ther"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01757-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01757-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01757-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:03:09Z","timestamp":1751382189000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01757-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1757"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01757-3","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal experiments were approved by the Institutional Animal Care and Use Committee of Xuanwu Hospital of Capital Medical University following the Guide for the Care and Use of Laboratory Animals (The application reference number is XW-20220613-1 and the approval date is June 13, 2022).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}